Reaction

Leiomyosarcoma reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 381 reports · 3 co-occurring drugs

As of the last recalculation, Leiomyosarcoma appears in 381 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 52.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Basiliximab1152.652.6
Pazopanib Hydrochloride2247.147.1
Gemcitabine1623.123.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.